Adamas Pharmaceuticals, Inc. today announced the presentation of two separate analyses of pooled data from the placebo-controlled Phase 3 clinical trials of ADS-5102 extended-release capsules in oral platform and poster presentation sessions at the 69 th American Academy of Neurology Annual Meeting in Boston. Adamas is excited to present this.
American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. "Iron deficiency affects up to half of all heart failure patients and is associated with impaired exercise tolerance, and mortality in patients with or without anemia, 2" said Adrian F. Hernandez,
By a News Reporter-Staff News Editor at Pharma Business Week- BioMarin Pharmaceutical Inc., announced that it has entered into a settlement agreement with Par Pharmaceutical that resolves patent litigation in the United States related to BioMarin's Kuvan 100 mg oral tablets and powder for oral solution in 100 mg packets. Under the terms of the
DURECT Corporation, a biopharmaceutical company actively developing new therapeutics based on its Epigenetic Regulator Program and proprietary drug delivery platforms, announced that clinical data on DUR-928 were presented at The International Liver Congress TM 2017 on April 22 in Amsterdam. "DUR-928 was well tolerated in this study and plasma..
By a News Reporter-Staff News Editor at Pharma Business Week Ferring Pharmaceuticals and Alrise Biosystems announced that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise's ImSus Technology Platform for the development of an injectable, controlled-release formulation of a...
Findings from University of Pittsburgh Update Knowledge of Drug Delivery Systems. According to news reporting originating in Pittsburgh, Pennsylvania, by NewsRx journalists, research stated, "We systematically reviewed preclinical and clinical studies on bladder chemodenervation with onabotulinumtoxin A to highlight current limitations and future..
Findings in the Area of Drug Delivery Systems Reported from Purdue University. Funders for this research include Lilly Endowment, National Institute of Biomedical Imaging and Bioengineering, China Scholarship Council, Eli Lilly and Company. The news correspondents obtained a quote from the research from Purdue University, "Subsequent treatment with
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Medical Imaging Drugs Advisory Committee to discuss new drug application 208-630 for 5- Aminolevulinic Acid Hydrochloride, Powder, for oral solution, submitted by NX Development Corp., an imaging agent to facilitate the real time detection and visualiza
By a News Reporter-Staff News Editor at Biotech Business Week UK biotech company Nemaura Pharma is continuing its growth plans with the appointment of leading global pharmaceutical expert Dr Werner Wessling. His early career in management with Beiersdorf AG and Altana AG subsequently led to his appointment in 1987 as VP Business Development world
By a News Reporter-Staff News Editor at Mental Health Weekly Digest Neurocrine Biosciences, Inc. announced that the U.S. Food and Drug Administration has approved INGREZZATM capsules for the treatment of adults with tardive dyskinesia. INGREZZA, a novel, selective vesicular monoamine transporter 2 inhibitor, is the first and only FDA- approved pr
By a News Reporter-Staff News Editor at Diabetes Week A patent by the inventors Mograbi, Josef; Atlas, Daphne; Keynan, Shoshana, filed on April 21, 2015, was published online on April 11, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9617301 is assigned to ONEDAY-BIOTECH AND PHARM
By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, filed on August 4, 2014, was published online on April 11, 2017. The patent's assignee for patent number 9616060 is Nektar Therapeutics. News ed
Portal Instruments, a clinical stage medical device start-up company announced today that it has received ISO 13485: 2012 Certification by the National Standards Authority of Ireland certifying body. ISO 13485: 2012, Quality Management Standard for Medical Devices is the international standard requirements for a comprehensive quality management..
HOUSTON and LOWELL, Mass., April 24, 2017/ PRNewswire/ DNAtrix, a clinical stage biotechnology company developing virus-based immunotherapies for cancer, and Alcyone Lifesciences, a leader in neural intervention systems and advanced drug delivery, will reveal clinical data demonstrating the precise administration of DNX-2401, an oncolytic adenovi
According to news reporting originating in Lugano, Switzerland, by NewsRx journalists, research stated, "One complication associated with the refill procedure of intrathecal drug delivery systems include a' pocket fill,' which is the inadvertent injection of the drug into the subcutaneous space surrounding the pump. For more information on this res
Our news journalists report that additional information may be obtained by contacting J. Hajjar, Texas Childrens Hosp, Baylor College of Medicine, Sect Immunol Allergy& Rheumatol, Houston, TX 77030, United States. Additional authors for this research include J. Hajjar, S. Bean, S.Q. Fu, D. Hong, D. Karp, B. Stephen, K. Hess, F. Meric-Bernstam and A
By a News Reporter-Staff News Editor at Diabetes Week New Rochelle, NY, A new study examining the risk of fasting during Ramadan for people with type 1 diabetes compared blood glucose control and the rates of hypoglycemia and hyperglycemia between users of insulin pump therapy versus multiple daily insulin injections. Reem Alamoudi, MD, MHSc, Ima
Sanofi today announced that the U.S. Food and Drug Administration approved Thymoglobulin , for use in conjunction with concomitant immunosuppression in the prophylaxis, or prevention, of acute rejection in patients receiving a kidney transplant. "Thymoglobulin has been a well-established medication used in kidney transplantation for nearly 20
By a News Reporter-Staff News Editor at Nanotechnology Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news originating from Taian, People's Republic of China, by VerticalNews correspondents, research stated, "A folic acid- functionalized drug vehicle platform based on Pluronic 12
Studies from Technical University of Denmark in the Area of Drug Delivery Systems Reported. According to news reporting originating in Lyngby, Denmark, by VerticalNews journalists, research stated, "For major advances in microfabricated drug delivery systems, fabrication methods with high throughput using biocompatible polymers are required.
By a News Reporter-Staff News Editor at Nanotechnology Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. For more information on this research see: A' grafting from' approach to polymer nanorods for pH-triggered intracellular drug delivery. Polymer, 2017; 112: 244-251. Polymer can be contacted a
Theravance Biopharma, Inc. today announced that new preliminary data from the ongoing Telavancin Observational Use Registry study are the focus of three poster presentations at the 27th European Congress of Clinical Microbiology and Infectious Diseases. The 27 th ECCMID is being held in Vienna, Austria, April 22-25, 2017. The TOUR findings being
By a News Reporter-Staff News Editor at Clinical Trials Week Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration has approved supplemental indications for Harvoni tablets and Sovaldi tablets for the treatment of chronic hepatitis C virus infection in adolescents without cirrhosis or with compensated cirrhosis, 12 year
Data on Clinical Trials and Studies Described by Researchers at Fred Hutchinson Cancer Research Center. According to news reporting originating in Seattle, Washington, by NewsRx editors, the research stated, "Before the 2009 Biologics Price Competition and Innovation Act that enabled the U.S. Federal Drug Administration to create the 351 Biologic L
Reddy s Laboratories Ltd., announced on April 21, 2017 that it has launched Progesterone Capsules, 100 mg and 200 mg in U.S. market Dr. Reddy s Laboratories Ltd. announced on April 21, 2017, that it has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium* capsules in the United States mark